Eli Lilly to Invest $5 Billion in Virginia Plant Amid Trump Tariff Threats
Eli Lilly will invest $5 billion in a new Virginia plant, expanding U.S. manufacturing in response to Trump's proposed pharmaceutical import tariffs.
South Korea’s KIET urges tailored support for domestic pharmaceutical exporters facing new US tariffs, highlighting the need to boost industry competitiveness and technological capabilities amid shifting US regulatory and trade policies.
#YonhapInfomax #PharmaceuticalTariffs #KIET #USRegulations #BiopharmaceuticalExport #TechnologicalCompetitiveness #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=72091
KIET Calls for Tailored Support in Response to US Pharmaceutical Tariffs—Emphasizes Need to Enhance Domestic Technological Capabilities
South Korea’s KIET urges tailored support for domestic pharmaceutical exporters facing new US tariffs, highlighting the need to boost industry competitiveness and technological capabilities amid shifting US regulatory and trade policies.
Celltrion has unveiled a comprehensive, phased strategy to mitigate potential impacts from proposed US pharmaceutical tariffs, including inventory buildup, local US production, and possible acquisition of US manufacturing facilities.
#YonhapInfomax #Celltrion #PharmaceuticalTariffs #USMarket #InventoryStrategy #CMO #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=71321
Celltrion Develops Step-by-Step Strategy to Address Potential US Pharmaceutical Tariffs
Celltrion has unveiled a comprehensive, phased strategy to mitigate potential impacts from proposed US pharmaceutical tariffs, including inventory buildup, local US production, and possible acquisition of US manufacturing facilities.
New York Stock Market Declines for Second Day Ahead of FOMC Meeting
New York stock market indices decline for second consecutive day as investors await FOMC meeting outcome, with major tech stocks and pharmaceuticals facing pressure amid tariff concerns
Trump - 'Auto Tariffs Will Be 25%'
Trump signals potential 25% auto tariffs and higher pharmaceutical tariffs, with announcements expected in early April, aiming to encourage domestic factory operations.
Yonhap Infomax News